Cargando…
High monoamine oxidase a expression predicts poor prognosis for prostate cancer patients
BACKGROUND: Monoamine oxidase A (MAOA) is a mitochondrial enzyme that is involved in prostate tumorigenesis and cancer metastasis. The predictive power of the preoperative clinical and pathological indicators for prostate cancer(PC) remains to be improved. To enrich evidence regarding the value of M...
Autores principales: | Chen, Lingxiao, Xiong, Wei, Qi, Lin, He, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318740/ https://www.ncbi.nlm.nih.gov/pubmed/37403079 http://dx.doi.org/10.1186/s12894-023-01285-8 |
Ejemplares similares
-
Monoamine oxidase A: An emerging therapeutic target in prostate cancer
por: Chen, Chia-Hui, et al.
Publicado: (2023) -
Low extracellular lysyl oxidase expression is associated with poor prognosis in patients with prostate cancer
por: Zheng, Wei, et al.
Publicado: (2016) -
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015) -
Monoamine Oxidase B Expression Correlates with a Poor Prognosis in Colorectal Cancer Patients and Is Significantly Associated with Epithelial-to-Mesenchymal Transition-Related Gene Signatures
por: Yang, Yi-Chieh, et al.
Publicado: (2020) -
Association of Monoamine Oxidase A with Tumor Burden and Castration Resistance in Prostate Cancer
por: Meenu, Meenakshi, et al.
Publicado: (2020)